Immunocompetent individuals who:

• are aged 65 or 70 years on 1 September 2024
• are aged 66 years on 1 September 2024 and have never received a shingles vaccine
• are aged between 71 years and 79 years, and have never received a shingles vaccine and Zostavax® is no longer available
• are currently aged 80 years or over, but received a first dose of Shingrix® before turning 80 years old and require a second Shingrix® dose to complete the course before their 81st birthday

Severely immunosuppressed [1] individuals from 1 September 2024, who:

• are aged 50 years and above, and meet the definition of severe immunosuppression.
• are aged between 18 and 49 years and receiving a stem cell transplant

Exclusion: Individuals who do not meet the criteria

Immunocompetent individuals on 1 September 2024 who:

• have not yet reached their 65th birthday
• are between 67 to 69 years of age
• are 80 years of age or over, except those who have received a partial course of Shingrix® (who are no longer eligible from their 81st birthday)

All individuals who:

• have had a confirmed anaphylactic reaction to a previous dose of varicella vaccine or to any component of the vaccine
• are suffering from acute severe febrile illness (the presence of a minor infection is not a contraindication for immunisation)
• have shingles infection with active lesions
• are pregnant
• have already received one dose of Zostavax® or two doses of Shingrix® prior to assessment
• have received a dose of Shingrix® in the last 8 weeks

[1] Immunocompromised individuals in this PGD, are those defined as severely immunosuppressed, as outlined in the Box in Chapter 28a